JUL 17, 2020 7:28 AM PDT

RNA Gene Editing Restores Rett's Syndrome Protein in Mouse Model

WRITTEN BY: Amanda Mikyska

Video:  Overview of how scientists edit an RNA sequence. 

 

Rett's syndrome is a chronic, neurological disorder that causes repetitive hand movements, and a combination of other complications relating to the respiratory system, loss of speech, and musculoskeletal system.  Currently, there is no cure for the disorder, caused by a small error in the DNA code of the MECP2 gene that interferes with the gene producing a functional protein. A new study from the Vollum Institute at the Oregon Health and Science University shows that fixing the RNA code in three different types of neurons restores half the normal amount of the MECP2 protein.

Previous studies from the same researchers show that a synthetic RNA guide can edit mice's genetic code. This study broadens that finding by showing that editing the genetic code is possible in multiple types of neurons and that it achieves the intended downstream effect by restoring MECP2 protein levels. 

Most of Rett's syndrome cases are caused by an A replacing a G in the DNA code, but many possible mutations cause MECP2 to lose its function. Researchers design the guide RNA to match each mouse's specific mutation and administer the guide RNA via an enzyme. The RNA approach was successful in three different types of neurons and restored the function of the gene and the presence of the protein. 

The next step is to inject the guide RNA, via viral vehicle, into the blood so that all cells in the brain would be subject to edit, and to discover side effects.

However, research also showed that the RNA approach resulted in the guide RNA editing places other than the MECP2 gene. No side effects were attributed to the off-target effects, but decreasing off-target edits and increasing editing efficiency is a top priority in future studies.

 

Sources: GEN, NIH, Rett Syndrome Research Trust, Sinnamon et. al.

About the Author
  • Amanda graduated from the University of Massachusetts Boston with a degree in Biology. After working in research on creating biochemicals from genetically engineered yeast, she started freelance science writing while traveling the world. Now, Amanda is a Lab Manager and Research Assistant at the the University of Central Florida, studying the molecular phylogeny of parasitic wasps. She writes about the latest research in Neuroscience, Genetics & Genomics, and Immunology. Interested in working on solutions for food/water security, sustainable fuel, and sustainable farming. Amanda is an avid skier, podcast listener, and has run two triathlons.
You May Also Like
JUL 20, 2020
Neuroscience
Phantom-Limb Pain Reduced by Brain-Computer Interface
JUL 20, 2020
Phantom-Limb Pain Reduced by Brain-Computer Interface
Phantom-limb pain is a condition in which amputees feel like their amputated limb is still attached to their bodies. Whi ...
AUG 29, 2020
Drug Discovery & Development
MDMA and LSD Combo to Enter Clinical Trials
AUG 29, 2020
MDMA and LSD Combo to Enter Clinical Trials
Scientists from the pharmaceutical company, MindMed, have announced the beginning of Phase 1 clinical trials to test Sch ...
SEP 07, 2020
Neuroscience
Researchers Identify 5 Kinds of Cat Owners
SEP 07, 2020
Researchers Identify 5 Kinds of Cat Owners
Conservationists have long been concerned about the number of animals caught by domestic cats. In the US alone, estimate ...
SEP 15, 2020
Drug Discovery & Development
Turmeric Better than Placebo for Osteoarthritis Pain
SEP 15, 2020
Turmeric Better than Placebo for Osteoarthritis Pain
Researchers from the University of Tasmania in Australia have found that an extract from turmeric is more effective than ...
OCT 21, 2020
Cannabis Sciences
Exercise Reverses Learning Impairments from Cannabinoid Issues
OCT 21, 2020
Exercise Reverses Learning Impairments from Cannabinoid Issues
While cannabinoids usually get attention for their recreational effects, these molecules play a role in several other pr ...
OCT 24, 2020
Clinical & Molecular DX
Software Flags Elevated Cerebral Palsy Risk in Premies
OCT 24, 2020
Software Flags Elevated Cerebral Palsy Risk in Premies
Diagnostic imaging scientists have developed a software tool for predicting the future onset of cerebral palsy in babies ...
Loading Comments...